ORBIMED ADVISORS LLC – Syndax Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$48.21M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+24.90%
quarter
Syndax Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.64% | -316.8K shares | 3.51M | $24.03 | 2.00M |
| Q2 2022 | share | Increase | +7.64% | 165K shares | 7.18M | $19.24 | 2.32M |
| Q1 2022 | share | Increase | +8.93% | 177K shares | -5.86M | $17.38 | 2.15M |
| Q4 2021 | share | Increase | +939.51% | 1.79M shares | 39.72M | $21.78 | 1.98M |
| Q3 2021 | share | Increase | 0.00% | 190.6K shares | 3.64M | $19.11 | 190.6K |
| Q1 2021 | share | Decrease | -100.00% | -1.17M shares | -26.04M | $22.36 | 0 |
| Q4 2020 | share | Increase | +7.02% | 76.8K shares | 9.89M | $22.24 | 1.17M |
| Q3 2020 | share | 0.00% | 0 shares | -66K | $14.76 | 1.09M | |
| Q2 2020 | share | Increase | +277.28% | 804.1K shares | 13.03M | $14.82 | 1.09M |
| Q1 2020 | share | Increase | +36.79% | 78K shares | 1.32M | $10.97 | 290K |
| Q4 2019 | share | 0.00% | 0 shares | 277K | $8.78 | 212K | |
| Q3 2019 | share | 0.00% | 0 shares | -390K | $7.47 | 212K | |
| Q2 2019 | share | 0.00% | 0 shares | 861K | $9.31 | 212K | |
| Q1 2019 | share | 0.00% | 0 shares | 170K | $5.25 | 212K | |
| Q4 2018 | share | Decrease | -51.49% | -225K shares | -2.58M | $4.45 | 212K |
| Q3 2018 | share | 0.00% | 0 shares | 463K | $8.08 | 437K | |
| Q2 2018 | share | 0.00% | 0 shares | -3.15M | $7.02 | 437K | |
| Q1 2018 | share | 0.00% | 0 shares | 2.39M | $14.23 | 437K | |
| Q4 2017 | share | 0.00% | 0 shares | -1.28M | $8.76 | 437K | |
| Q3 2017 | share | 0.00% | 0 shares | -992K | $11.7 | 437K | |
| Q2 2017 | share | Decrease | -9.86% | -47.8K shares | -546K | $13.97 | 437K |
| Q1 2017 | share | Decrease | -35.99% | -272.56K shares | 1.22M | $13.72 | 484.8K |
| Q4 2016 | share | 0.00% | 0 shares | -6.05M | $7.17 | 757.36K | |
| Q3 2016 | share | 0.00% | 0 shares | 4.02M | $15.16 | 757.36K | |
| Q2 2016 | share | 0.00% | 0 shares | -2.62M | $9.85 | 757.36K | |
| Q1 2016 | share | Increase | 0.00% | 757.36K shares | 10.08M | $13.32 | 757.36K |